IP Library Granted Patent US 12,728,145
Granted Patent B2
US 12,728,145 · App. 18/074,255 · Granted Sep 8, 2026

Mangosteen pericarp extractand process for its preparation thereof

Inventors: Chia-Wen Chen (Taipei, TW); Rong-Hong Hsieh (Taipei, TW); Yen-Ting Chen (Taipei, TW); Yin-Jun Chen (Taipei, TW); Hsin Yuan (Taipei, TW); Chih-Hsin Huang (Taipei, TW)
Assignee: JUNHONG BIOTECHNOLOGY CO., LTD.
A61K36/38A23K10/30A23L33/105A23L33/40A61K31/352B01D11/0288A23V2002/00A61K2236/17A61K2236/33A61K2236/53
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,728,145
App. No.
18/074,255
Granted
Sep 8, 2026
Kind
B2
Abstract

The present invention discloses a mangosteen pericarp extract and process for its preparation thereof. The mangosteen pericarp extract containing α-mangostin and γ-mangostin which obtains from preparation steps comprising fragmentation, organic solvent soaking, aqueous solution, or acidic solution soaking, concentration, spray drying and grinding steps from the rind of the mangosteen. The present invention has advantages of simple preparation process to address efficiency issue, no need to have heating under reflux in extraction steps and the solvents which used are friendly to human body and environment. The mangosteen pericarp extract (α-Xones Prime) can significantly decrease insulin resistance, and bodyweight gain induced by daily high fat diet intake. In addition, administration of the mangosteen pericarp ethanolic extract can reduce fat accumulation in the adipose and muscle tissue of rats with daily high fat diet intake. The α-Xones Prime could be used as a nutraceutical ingredient for weight control or weight loss, or even prevention of metabolic syndrome and diabetes, and developed into a candidate drug composition.

Claims (1)

1 . A method for inhibiting weight gain, insulin resistance, and fat accumulation in adipose and muscle tissue induced by a high fat diet in a human in need thereof consisting essentially of administering to the human in need thereof a therapeutically effective amount of an extract of mangosteen pericarp, wherein the extract of the mangosteen pericarp extract is made by a process consisting essentially of: a) drying and fragmenting a mangosteen pericarp to obtain a fragment of the mangosteen pericarp; b) soaking the fragment of the mangosteen pericarp in at least 70% ethanol to yield a mangosteen pericarp extract and holding it at room temperature; c) filtering the mangosteen pericarp extract to obtain a mangosteen pericarp organic solvent extract, wherein the ratio of the weight to volume of the fragment of mangosteen pericarp and the organic solvent is 1:2 to 1:20; d) soaking and heating the fragment of mangosteen pericarp organic solvent extract of step c) in an aqueous solution and holding it at room temperature; e) filtering it to obtain a mangosteen pericarp aqueous extract and a mangosteen pericarp residue, wherein the ratio of the weight to volume of the fragment of mangosteen pericarp and the aqueous solution is 1:10 to 1:20; f) concentrating the mangosteen pericarp organic solvent extract and the mangosteen pericarp aqueous extract to obtain a mangosteen pericarp organic solvent concentrate and a mangosteen pericarp aqueous concentrate; g) adding the mangosteen pericarp organic solvent concentrate to an aqueous solution; h) homogenizing it, holding it at room temperature; i) separating it into a first upper layer aqueous solution and a first lower layer precipitate; j) isolating the first upper layer aqueous solution and adding ethanol to dissolve the first lower layer precipitate; k) obtaining a mangosteen pericarp ethanol extract by filtration; l) adding alkane solvent with a volume ratio of 1:1 to 1:10 into the mangosteen pericarp ethanol extract and mixing it with a vortex mixer, holding it at room temperature; m) separating it into an upper layer alkane solvent and a lower layer ethanol filtrate; n) heating and concentrating the lower layer ethanol filtrate in water bath to obtain a lower layer ethanol concentrated filtrate; o) adding and mixing aqueous solution with a volume ratio of 1:1 to 3:1 into the lower layer ethanol concentrated filtrate, holding it at low temperature; p) separating it into a second upper layer aqueous solution and a second lower layer precipitate; and q) fragmenting, air-lay drying and grinding the second lower layer precipitate to obtain the mangosteen pericarp ethanol extract.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 3, 2023
From: CHEN, CHIA-WEN; HSIEH, RONG-HONG; CHEN, YEN-TING; CHEN, YIN-JUN; YUAN, HSIN; HUANG, CHIH-HSIN
To: JUNHONG BIOTECHNOLOGY CO., LTD.
Reel/Frame 062259/0731 →
Priority Claims (1)
TW 109124499 · Jul 21, 2020 · national
Continuity (2)
Continuation In Part 17380408 · Jul 20, 2021
Related Publication 20230149491A1 · May 18, 2023
References Cited (19)
US 7285672B2 · Sobotta et al. · 2007 [cited by applicant]
US 10471114B2 · Gokaraju et al. · 2019 [cited by applicant]
US 20060088643A1 · Fugal et al. · 2006 [cited by applicant]
CN 102241659A · 2011 [cited by applicant]
CN 101525328B · 2012 [cited by applicant]
CN 103467433A · 2013 [cited by applicant]
JP WO2006137139A1 · 2009 [cited by applicant]
TW I627960B · 2018 [cited by applicant]
WO WO2006137139A1 · 2006 [cited by applicant]
Thomas EL, Frost G, Taylor-Robinson SD, Bell JD. Excess body fat in obese and normal-weight subjects. Nutr Res Rev. Jun. 2012;25(1):150-61. [cited by applicant]
Fukuda T, Bouchi R, Takeuchi T, Nakano Y, Murakami M, Minami I, Izumiyama H, Hashimoto K, Yoshimoto T, Ogawa Y. Ratio of visceral-to-subcutaneous fat area predicts cardiovascular events in patients with type 2 diabetes.… [cited by applicant]
Miao Z, Alvarez M, Ko A, Bhagat Y, Rahmani E, Jew B, Heinonen S, Muñoz-Hernandez LL, Herrera-Hernandez M, Aguilar-Salinas C, Tusie-Luna T, Mohlke KL, Laakso M, Pietiläinen KH, Halperin E, Pajukanta P. The causal effect … [cited by applicant]
Wali JA, Jarzebska N, Raubenheimer D, Simpson SJ, Rodionov RN, O'Sullivan JF. Cardio-Metabolic Effects of High-Fat Diets and Their Underlying Mechanisms—A Narrative Review. Nutrients. May 21, 2020;12(5):1505. [cited by applicant]
Lee YS, Li P, Huh JY, Hwang IJ, Lu M, Kim JI, et al. Inflammation is necessary for long-term but not short-term high-fat diet-induced insulin resistance. Diabetes. 2011; 60:2474-2483. [cited by applicant]
Roel A van der Heijden, Fareeba Sheedfar, Martine C Morrison, Pascal PH Hommelberg, Danny Kor, Niels J Kloosterhuis, Nanda Gruben, Sameh A Youssef, Alain de Bruin, Marten H Hofker, Robert Kleemann, Debby PY Koonen, Pete… [cited by applicant]
Chen LG, Yang LL, Wang CC. Anti-inflammatory activity of mangostins from Garcinia mangostana. Food Chem Toxicol. 2008; 46:688-693. [cited by applicant]
Chairungsrilerd N, Furukawa K, Ohta T, Nozoe S, Ohizumi Y. Histaminergic and serotonergic receptor blocking substances from the medicinal plant [cited by applicant]
Li D, Liu Q, Lu X, Li Z, Wang C, Leung CH, Wang Y, Peng C, Lin L. α-Mangostin remodels visceral adipose tissue inflammation to ameliorate age-related metabolic disorders in mice. Aging (Albany NY) 2019; 11:11084-11110. [cited by applicant]
Jiang HZ, Quan XF, Tian WX, Hu JM, Wang PC, Huang SZ, Cheng ZQ, Liang WJ, Zhou J, Ma XF, Zhao YX. Fatty acid synthase inhibitors of phenolic constituents isolated from Garcinia mangostana. Bioorg Med Chem Lett. Oct. 15,… [cited by applicant]